TargetCancer Fdn

Advancing the development of more effective and personalized treatments for people with #RareCancers

[TargetCancer Fdn @targetcancer]

Grateful to our #TCFThinkTank2026 sponsors
@AstraZeneca, @Boehringer, @FoundationATCG, @JazzPharma, @EliLillyandCo, @ServierPharma, & @TaihoOncology for their commitment to advancing #PrecisionMedicine and supporting patients with #RareCancers

[Shuhan @Shuhanoo]

@waraonc23 @targetcancer @Dr_R_Kurzrock @VivekSubbiah @chadinabhan @bickythapa02 @UCSDCancer @MCWCancerC2u8v @Perlmutter_CC @DanaFarber_GU @FoundationOne @TempusAI Now *this* is a truly valuable gathering! Bringing together experts from diverse fields to tackle the challenges of rare tumors that is truly admirable! 👏 I look forward to seeing these discussions translate into real-world outcomes that benefit more patients! Keep it up! 💪

[Yu (Fuji) Fujiwara, MD | 藤原 裕 (腫瘍内科医/早期臨床試験) @waraonc23]

Phenomenal conference! Thank you @targetcancer for organizing this amazing meeting to learn more about rare cancer care/research and connect to people working on tumor-agnostic research. A lot to discuss: ag(e)nostic, zip-code agnostic, funding, CUP, advocacy networking, more!

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Clonal evolution. Wheler was here too but she left before the photo. Proud of these mentees and wonderful opportunity to see them at TargetCancer Foundation meeting for rare cancers. 🧨🦄🦓🎯💡👏

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Definitely best meeting for rare cancers. Honored to chair meeting and to hear Subbiah amazing talk 🔥🔥🦄🦓

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

TargetCancer meeting for rare cancers in Boston. Wonderful meeting. Conference hall is not too shabby🧨🧨🎯🦓🦄

[TargetCancer Fdn @targetcancer]

In the middle of an inspiring day of impact and innovation at the 5th Annual Think Tank on Advancing #PrecisionMedicine in #RareCancers!

Thank you to our speakers and attendees driving innovation and hope for patients 💚

#TCFThinkTank2026 #RCTT2026

[Jessica Stone @JessicaStoneTV]

@VivekSubbiah @targetcancer @Dr_R_Kurzrock @ASCO @montypal @PGrivasMDPhD @doctorpemm @DrChoueiri @weldeiry @GlopesMd @chadinabhan @BenWestphalen @SewantiLimaye Glad to meet you in person finally!

[Vivek Subbiah, MD @VivekSubbiah]

⭐️One of my favorite meetings of the year is today: Target Cancer Foundation's Rare Cancer Precision Oncology meeting. @targetcancer @Dr_R_Kurzrock
⭐️Looking forward to delivering my lecture “AGNOSTIC BY DESIGN: Five Years That Redrew the Map of Rare Cancer Precision Oncology, & the Next Frontier” 🧬🎯🚀@OncoAlert @oncodaily @OncBrothers @OpenMedInsights @OpenMedKate
#TCFTargetcancer2026
#RareCancer #PrecisionOncology
https://t.co/kKlAXsRvc1

[TargetCancer Fdn @targetcancer]

Exciting News: We're thrilled to launch the TCF Think Tank Accelerator Program! On Nov 11, we co-host the 1st #MyoepithelialCarcinoma scientific meeting with cureMEC to kick off this new initiative supporting different #RareCancers each year.

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

Sold out 🔥🔥🔥

[TargetCancer Fdn @targetcancer]

#TCFThinkTank2026 is 1 week away!

We're honored to welcome #PrecisionMedicine experts @Dr_R_Kurzrock, @DrEzraCohen, @chadinabhan, & @corrie_painter for Session 1: Rewriting #RareCancer Outcomes.

Registration is at capacity. Learn more: https://t.co/a4GWkb2X6S

[TargetCancer Fdn @targetcancer]

At #NORDSummit, TCF CEO Jim Palma moderated a discussion on #BiomarkerTesting access.

25 states have passed coverage laws, but true progress requires empowering #RareCancer patients to share their experiences.

#PatientAdvocacy

[National Organization for Rare Disorders (NORD) @RareDiseases]

Advances in precision #oncology are creating new opportunities for people living with rare #cancer, but access to biomarker testing remains uneven in many states.

Yesterday's #NORDSummit panel on Closing the Gap in Precision Oncology with @ACSCAN, @ChildrensNatl, and NJ Senator Troy Singleton (@Troy4NJ7) explored the policy solutions and patient advocacy needed to expand equitable access to testing.

#HealthEquity #biomarkers

[National Organization for Rare Disorders (NORD) @RareDiseases]

In our #NORDSummit panel, Closing the Access Gap in Precision Oncology, our panelists highlighted the power that #biomarker testing has for #cancer patients and how too many people lack access to it. The science is already here, the problem is affordability and access.

NJ State Senator @Troy4NJ7 explained how #NewJersey passed a law requiring #HealthInsurance coverage for biomarker testing. This must be a #HealthEquity model for other states to follow, and about half of states so far have.

Thank you to our panelists from @ChildrensNatl, @ACSCAN and moderator Jim Palma of @TargetCancer

[TargetCancer Fdn @targetcancer]

We're honored to have you on our team
#MilesForTochi #RunningAgainstRareCancers

[Chinenye Ugoji @chinenyeug]

In memory of my sister, Tochi🎀, I’m running the 2027 @bostonmarathon💙Through #MilesForTochi #HopeForRareCancers I’m raising $15,000 for @targetcancer towards rare cancer research. Every mile has a purpose. Every gift creates hope. Pls donate or share🙏🏽

https://t.co/BRNWK0N1gP

[TargetCancer Fdn @targetcancer]

Meet #TeamTCF27!

Learn what motivates them to run the #BostonMarathon & help them reach their fundraising goals:
👉 https://t.co/wJfP0mFvFZ 👈

#RunningAgainstRareCancers

[TargetCancer Fdn @targetcancer]

On Tues. Oct 27, TCF CEO Jim Palma moderates "Closing the Access Gap in Precision Oncology" at the #NORDSummit in DC with expert panelists Dr. Urania Dagalakis, Hilary Gee Goeckner, & Sen. Troy Singleton: https://t.co/L8CAgbn6sM

#PrecisionOncology #RareCancers #TargetCancer

[TargetCancer Fdn @targetcancer]

"What I thought was a job turned out to be a passion."

Everyday, TRACK study team member Mary Oster connects with #RareCancer patients nationwide to help them understand how the TCF-001 TRACK study works.

Thank you, Mary, for your dedication! #FacesofTCF

[TargetCancer Fdn @targetcancer]

Grateful to be a part of this important conversation 💚

We look forward to continuing the dialogue about the future of CUP at our upcoming Think Tank on Advancing Precision Medicine in Rare Cancers in Boston on November 12th.

#CancerOfUnknownPrimary #TCFThinkTank2026

[Ryan Huey, MD, MS @ryanhuey]

Recently had the chance to speak about CUP and future perspectives with friends at @CupAwareness @targetcancer https://t.co/sp8w4Krdxs

[TargetCancer Fdn @targetcancer]

In our latest OnTarget blog post, Brain Tumor Research Tech Andrew Venuti shares what he learned about the future of rare cancer care while attending the 2025 Think Tank on Advancing Precision Medicine in Rare Cancers.

Read about his experience: https://t.co/wEK1evskCx